Archives
-
Firefly Luciferase mRNA as an LNP Assay Control
2026-08-12
Firefly Luciferase mRNA can do more than report gene expression: it can help separate RNA quality, nanoparticle processing, and cellular translation in LNP studies. This article connects Cap1/5-moUTP design with recent evidence on concentrated LNP manufacturing to improve assay interpretation.
-
Dimetridazole Targets P. aeruginosa Quorum Sensing
2026-08-12
Yuan et al. (2022) show that Dimetridazole and Ribavirin can attenuate Pseudomonas aeruginosa virulence by suppressing quorum-sensing-regulated phenotypes rather than acting mainly as conventional antibiotics. The study integrates phenotypic assays, transcriptomics, antibiotic-combination testing, and C. elegans and mouse infection models to support an antivirulence repurposing strategy.
-
Cy5-UTP RNA Labeling: Workflow and Applications
2026-08-11
Cy5-UTP enables direct fluorescent RNA probe synthesis during T7 in vitro transcription, reducing dependence on post-labeling or staining steps. This guide connects practical labeling workflows with FISH, dual-color arrays, and sequence-specific RNA interaction studies inspired by recent MALAT1 research.
-
Trelagliptin, RUNX2, and Osteoblastic Differentiation
2026-08-11
The reference study identifies a previously underexplored effect of the DPP-4 inhibitor trelagliptin: enhancement of osteoblastic differentiation and mineralization in MC3T3-E1 cells. Its data implicate AMPK activation and increased RUNX2 expression, providing a mechanistic basis for investigating trelagliptin in osteoporosis while remaining limited to an in vitro model.
-
Selective Magnetic Stimulation Targets GABRE in Mice
2026-08-10
A Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a molecular target of selective magnetic stimulation. Using behavioral, synaptic, genetic, and protein-pathway experiments, the authors show that c-MSST can reverse MK-801-associated schizophrenia-like phenotypes and implicate p62/SQSTM1-mediated regulation of GABARAP family proteins.
-
Verbascoside and Context-Aware NF-κB Translation
2026-08-09
A translational framework for using Verbascoside to interrogate PKC/NF-κB signaling, osteoclastogenesis, and the context-dependent biology revealed by recent osteonecrosis research.
-
EZ Cap™ EPO mRNA for Translational Research
2026-08-08
EZ Cap™ EPO mRNA combines Cap 1 capping, pseudouridine, and a poly(A) tail for controlled human EPO expression in mammalian research systems. This guide translates the reagent into practical workflows for erythropoiesis, protein expression, nanoparticle delivery, and neurorepair studies, with troubleshooting strategies for RNA handling and biological variability.
-
Tracking Lysosome State in Nanovaccine Translation
2026-08-07
A mechanistic and translational framework for using Lyso-Tracker Red to connect lysosomal trafficking, antigen processing, and immune-response design in live-cell nanovaccine research.
-
Proteinase K: Broad-Spectrum Serine Protease for DNA Isolati
2026-08-07
APExBIO’s Proteinase K streamlines DNA isolation by delivering robust protein hydrolysis even in challenging environments, ensuring high DNA integrity. Its broad-spectrum serine protease activity and resistance to common inhibitors make it a superior choice for demanding molecular biology workflows.
-
Vancomycin Hydrochloride: Applied Workflows in Resistance As
2026-08-06
Vancomycin hydrochloride, a gold-standard glycopeptide antibacterial agent, is indispensable for benchmarking antibiotic resistance, optimizing selective media, and modeling Gram-positive infections in the laboratory. This article distills practical protocols, real-world troubleshooting, and innovative research frontiers leveraging the unique properties of Vancomycin hydrochloride from APExBIO.
-
Bestatin Hydrochloride: Applied Workflows in Angiogenesis In
2026-08-06
Bestatin hydrochloride (Ubenimex) is redefining experimental rigor in tumor growth and neuropeptide signaling research by delivering robust, reproducible inhibition of aminopeptidase activity. This article details stepwise protocols, troubleshooting strategies, and the translational value of Bestatin hydrochloride, leveraging both foundational and current literature for optimized lab outcomes.
-
Scenario-Driven Solutions with EZ Cap™ Cy5 Firefly Luciferas
2026-08-05
This article explores how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) (SKU R1010) addresses critical challenges in cell-based assays, from transfection reproducibility to real-time mRNA tracking. Integrating data-backed best practices and direct product comparisons, the guide empowers biomedical researchers to optimize gene expression studies and assay reliability.
-
Structure-Based Discovery of SARS-CoV-2 NSP15 Inhibitors
2026-08-05
This study leverages structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease central to immune evasion. The findings highlight new avenues for antiviral development by targeting viral mechanisms distinct from conventional replicase inhibitors.
-
FLCN mRNA Rescue in Birt-Hogg-Dubé Syndrome: New Mutations,
2026-08-04
This study uncovers novel and pathogenic FLCN mutations in Chinese Birt-Hogg-Dubé syndrome patients and demonstrates that exogenous FLCN mRNA delivery restores protein function and corrects mTORC1 signaling in vitro. These findings lay foundational evidence for mRNA-based intervention strategies targeting loss-of-function genetic disorders.
-
UTP Solution (100 mM): Precision Nucleotide for RNA Assays
2026-08-04
UTP Solution (100 mM) from APExBIO delivers unmatched purity and stability, empowering high-fidelity RNA synthesis, epigenetic research, and advanced transcription workflows. This article guides you from setup to troubleshooting, integrating the latest insights on olfactory gene regulation and practical protocol enhancements.